Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate.

AUTOR(ES)

Duncan, J S

RESUMO

A prospective, double-blind, placebo-controlled investigation of possible withdrawal symptoms from phenytoin, carbamazepine and sodium valproate is reported in patients with active epilepsy, on combination therapy. There was an increase in seizures on reduction and withdrawal of carbamazepine, but there was no convincing evidence of withdrawal symptoms from any of these drugs.

Documentos Relacionados

• Carbamazepine, phenytoin and sodium valproate monotherapy.
• Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial.
• Carbamazepine, phenytoin, and the fetus
• Complex partial seizures: EEG foci and response to carbamazepine and sodium valproate.
• Gingival hyperplasia due to sodium valproate.